Cervical Local Immune Response for High-Risk Human Papillomavirus Infection: Involvement With Cervical Mucus SLPI Proteins

---

Copy For Citation

Sahin E., MADENDAĞ Y., SAHIN M. E., MADENDAG I. C., AÇMAZ G., Karakukcu C., ...More

CANCER CONTROL, vol.25, no.1, 2018 (SCI-Expanded)

• Publication Type: Article / Article
• Volume: 25 Issue: 1
• Publication Date: 2018
• Doi Number: 10.1177/1073274818798598
• Journal Name: CANCER CONTROL
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Keywords: cervical immune response, human papillomavirus, high-risk HPV, LGSIL, HGSIL, secretory leukocyte protease inhibitor (SLPI), LEUKOCYTE PROTEASE INHIBITOR, CANCER, EXPRESSION, INDUCTION
• Erciyes University Affiliated: Yes

Abstract

Purpose: To evaluate cervical mucus secretory leukocyte protease inhibitor (SLPI) concentrations in patients with high-risk human papillomavirus (hrHPV) 16 or 18 positive and low-grade squamous intraepithelial lesions (LGSIL) or high-grade squamous intraepithelial lesions (HGSIL).